Back to search

Article

Academic challenges on ATMPs’ development: a regulatory perspective

2023-08-28

Abstract excerpt

Advanced therapy medicinal products (ATMPs) are becoming the new kid on the block for the treatment of a variety of indications with promising results. Academic centres have often been at the forefront of basic research, preclinical phases, and translational studies for the clinical development of ATMPs for several approved drugs. Despite the academic contribution to the basic and clinical research of ATMPs, under...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
69d04ee3-d900-567e-a2a6-559b14284115
DOI
10.22541/au.169323509.90988376/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Academic challenges on ATMPs’ development: a regulatory perspectiveDOI 10.22541/au.169323509.90988376/v1
U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Semantic proximity
A Decade of Innovation: Medicinal Products with New Active Substances Centrally Authorized Within EU Between 2011 and 2020Semantic proximity
Advancing Potency Assay Development for Advanced Therapy Medicinal Products: A Comprehensive Approach and Regulatory InsightsSemantic proximity
Beyond QTPP: Introducing the Quality Target Administration (QTAP) Profile for Enteral Feeding Tube MedicationsSemantic proximity
Pharmaceutical Drug Lifecycle: A Comprehensive Scientific Review of Research and Development Phases, Attrition Rates, and Global DisparitiesSemantic proximity
DRUG REPURPOSING-Overcoming the translational hurdles to clinical use.Semantic proximity
Rare Diseases Clinical Trials Toolbox - Public resources and main considerations to set up a clinical trial on medicinal products for humans in EuropeSemantic proximity
Development Analysis and Strategic Insights from a 505(b)(2) Reformulation Product: EnzalutamideSemantic proximity
Ensuring Quality Medicine: A Comprehensive Overview of EMA and DGDA's History, Structure, and Functions.Semantic proximity
Analysis of Patient Access to Orphan Drugs in TurkeySemantic proximity
Deficiency Patterns in FDA Complete Response Letters for New Drug and Biologics Applications: A Cross-Sectional AnalysisSemantic proximity
Developing Generic Templates to Shape the Future for Conducting Integrated Research Platform TrialsSemantic proximity
Select a neighboring publication to make it the new centre.